These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31332475)

  • 1. Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients-a case-control study.
    van Wassenaer EA; Meester VL; Kindermann A; Koot BGP; Benninga MA; de Meij TGJ
    Eur J Clin Pharmacol; 2019 Oct; 75(10):1445-1450. PubMed ID: 31332475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease-A Single Center Case-Control Study.
    Szymanska E; Dadalski M; Sieczkowska-Golub J; Jarzebicka D; Meglicka M; Osiecki M; Wiernicka A; Lebensztejn DM; Korczowski B; Kierkus J
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Gold SL; Cohen-Mekelburg S; Schneider Y; Shen N; Faggen A; Rupert A; Scherl EJ; Bosworth B; Steinlauf A
    Inflamm Bowel Dis; 2017 Oct; 23(10):1882-1889. PubMed ID: 28837521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premedication prevents infusion reactions and improves retention rate during infliximab treatment.
    Bartoli F; Bruni C; Cometi L; Blagojevic J; Fiori G; Tofani L; Galluccio F; Furst DE; Matucci Cerinic M
    Clin Rheumatol; 2016 Nov; 35(11):2841-2845. PubMed ID: 27436188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry.
    Choquette D; Faraawi R; Chow A; Rodrigues J; Bensen WJ; Nantel F
    J Rheumatol; 2015 Jul; 42(7):1105-11. PubMed ID: 26077415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological Study.
    Tran-Minh ML; Gornet JM; Maillet M; Houze P; Simon M; McLellan P; Hassid D; Vivier-Chicoteau J; Baudry C; Hammoudi N; Allez M
    J Crohns Colitis; 2021 May; 15(5):742-748. PubMed ID: 33205193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
    Fumery M; Tilmant M; Yzet C; Brazier F; Loreau J; Turpin J; Le Mouel JP; Goeb V; Nguyen-Khac E; Singh S; Dupas JL; Diouf M
    Dig Liver Dis; 2019 Apr; 51(4):484-488. PubMed ID: 30686715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated with Infusion Reactions to Infliximab in Chinese Patients with Inflammatory Bowel Disease: A Large Single-Center Study.
    Wang X; Cao J; Wang H; Ye C
    Med Sci Monit; 2019 Mar; 25():2257-2264. PubMed ID: 30917108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in inflammatory bowel disease. Is premedication necessary?
    Nuñez F P; Quera R; Simian D; Flores L; Figueroa C; Ibañez P; Kronberg U; Lubascher J; Pizarro G
    Gastroenterol Hepatol; 2021 May; 44(5):321-329. PubMed ID: 33386199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab in pediatric rheumatology patients: a retrospective analysis of infusion reactions and severe adverse events during 2246 infusions over 12 years.
    Aeschlimann FA; Hofer KD; Cannizzaro Schneider E; Schroeder S; Lauener R; Saurenmann RK
    J Rheumatol; 2014 Jul; 41(7):1409-15. PubMed ID: 24833759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium.
    Jacobstein DA; Markowitz JE; Kirschner BS; Ferry G; Cohen SA; Gold BD; Winter HS; Heyman MB; Baldassano RN
    Inflamm Bowel Dis; 2005 May; 11(5):442-6. PubMed ID: 15867583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Accelerated Infliximab Infusions in Children With Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Jagt JZ; Galestin SE; Claesen J; Benninga MA; de Boer NKH; de Meij TGJ
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):373-380. PubMed ID: 37319101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Rapid Infliximab Infusions in Children: A Systematic Review.
    van Wassenaer EA; van Oosterhout JPM; Daams JG; van den Berg MJM; van der Lee H; D'Haens GR; de Meij TGJ; Benninga MA; Koot BGP
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):361-365. PubMed ID: 32558671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    El-Matary W; Dykes DMH; Bauman L; Elkadri A; Carroll MW; Izaguirre MR; deBruyn J; Samson CM; Crim AM; Ali S; Grossman A
    Inflamm Bowel Dis; 2017 Dec; 23(12):2104-2108. PubMed ID: 29140940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PREMEDICATION WITH CORTICOSTEROIDS PRIOR TO IV INFLIXIMAB - A COMPARISON BETWEEN INFLAMMATORY BOWEL DISEASE (IBD) AND RHEUMATIC PATIENTS].
    Oshri D; Schwarz D; Vodonos A; Zimhony N; Abu-Shakra M; Zeller L
    Harefuah; 2019 Sep; 158(9):571-575. PubMed ID: 31507106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute adverse events related to infliximab infusions in pediatric patients.
    Lahdenne P; Wikström AM; Aalto K; Kolho KL
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):785-90. PubMed ID: 20535789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability.
    Bohra A; Rizvi QA; Keung CYY; Vasudevan A; van Langenberg DR
    World J Gastroenterol; 2020 Sep; 26(36):5437-5449. PubMed ID: 33024395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
    Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
    Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
    Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
    Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
    Ma D; Wong W; Aviado J; Rodriguez C; Wu H
    Am J Gastroenterol; 2019 Feb; 114(2):352-354. PubMed ID: 30333541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.